• Optimizing Cancer Assays with BV6: From IAP Antagonism to Ra

  2026-06-11

  BV6, a potent IAP antagonist, empowers researchers to reliably induce apoptosis and sensitize cancer cells to chemoradiotherapy. This article dives into advanced workflows, actionable troubleshooting, and protocol optimization, bridging foundational mechanism with practical assay outcomes.

• EPI-001: Unraveling AR N-Terminal Domain Inhibition in Cance

  2026-06-11

  Explore the advanced applications of EPI-001, a potent androgen receptor N-terminal domain inhibitor, in prostate and triple-negative breast cancer research. This article provides a deep dive into its molecular mechanism, protocol optimization, and translational impact, offering uniquely actionable insights for AR-driven disease models.

• Applied Workflows for Resiniferatoxin (RTX) in TRPV1 Researc

  2026-06-10

  Resiniferatoxin (RTX) enables ultra-selective, long-lasting TRPV1 desensitization, offering unmatched control in pain and neurogenic inflammation models. This guide translates recent mechanistic insights and reference-backed troubleshooting into actionable protocols for reproducible, high-impact research.

• Triacetin Digestion and Hepatic Metabolic Regulation in Rats

  2026-06-10

  This study elucidates the complete digestive fate of triacetin, a short-chain triglyceride, in rats. The findings reveal that triacetin is fully degraded in the upper gastrointestinal tract and its metabolites directly modulate hepatic energy metabolism, offering new insights for metabolic research.

• Non-Canonical Dlat-Trpv3 Pathway Drives Adipose Thermogenesi

  2026-06-09

  This study demonstrates that hyperforin activates adipose thermogenesis via the Dlat-Trpv3-Ca2+-AMPK axis, offering a distinct alternative to β3-adrenergic stimulation for obesity control. The findings reveal a mechanistic avenue with minimal cardiotoxicity and suggest new strategies for metabolic intervention.

• Difloxacin HCl: Beyond Antimicrobial Testing to Cell Cycle I

  2026-06-09

  Explore the dual role of Difloxacin HCl as a quinolone antimicrobial antibiotic and a tool for probing cell cycle checkpoint regulation. This article uniquely bridges antimicrobial susceptibility testing with advanced oncology research applications.

• EPI-001: Androgen Receptor N-Terminal Domain Inhibitor Workf

  2026-06-08

  EPI-001, a potent androgen receptor N-terminal domain inhibitor, uniquely targets both full-length AR and its splice variants, overcoming resistance mechanisms in prostate and triple-negative breast cancer models. This article delivers actionable workflows, protocol refinements, and troubleshooting strategies for maximizing the compound’s translational impact in AR-driven oncology research.

• 10074-G5: Advanced Insights into c-Myc Inhibition and Cancer

  2026-06-08

  Explore the molecular intricacies of 10074-G5, a leading c-Myc inhibitor, and its role in disrupting oncogenic signaling for cancer research. This article offers a uniquely in-depth analysis of c-Myc/Max dimerization inhibition and practical guidance for translational assay design.

• Trichostatin A (TSA): Precision Epigenetic Modulation in Can

  2026-06-07

  Trichostatin A (TSA) empowers researchers to dissect epigenetic regulation in cancer and bone biology with robust, reproducible workflows. Recent breakthroughs reveal TSA’s unique role in enhancing titanium implant integration via oxidative stress modulation, positioning it as a versatile tool for both oncology and regenerative medicine applications.

• D-Luciferin Sodium Salt: Precision Firefly Luciferase Substr

  2026-06-06

  D-Luciferin sodium salt is the gold-standard firefly luciferase substrate enabling high-sensitivity, ATP-dependent bioluminescence assays for in vivo and in vitro applications. Recent advances in CAR macrophage imaging and immunotherapy research reveal new frontiers for reproducible, quantitative metabolic monitoring in oncology. Discover parameter-rich protocols, troubleshooting insights, and the pivotal role of APExBIO’s D-Luciferin sodium salt in next-generation cellular assays.

• GSK621: Uncovering AMPK-Driven Immunometabolic Reprogramming

  2026-06-05

  Explore how the potent AMPK agonist GSK621 enables advanced research into immunometabolic reprogramming and apoptosis induction in AML cells. This article reveals deeper mechanistic insights and practical assay guidance beyond existing literature.

• WP1066: Redefining JAK2/STAT3 Modulation in Translational Re

  2026-06-05

  Explore the mechanistic, experimental, and translational landscape of WP1066—a potent, cell-permeable JAK2/STAT3 inhibitor—across oncology and regenerative medicine. This thought-leadership article addresses pathway rationale, evidence-backed protocols, emerging competitive strategies, and the future horizon for translational researchers pursuing next-generation therapeutics.

• EdU Flow Cytometry Assay Kits (Cy3): Precision in DNA Replic

  2026-06-04

  EdU Flow Cytometry Assay Kits (Cy3) deliver high-fidelity detection of S-phase DNA synthesis, outperforming traditional BrdU protocols for cell proliferation studies. This article details experimental workflows, advanced troubleshooting, and actionable insights from the latest breast cancer research—empowering researchers to achieve reproducible, multiplexed cell cycle analysis.

• EZ Cap™ Firefly Luciferase mRNA (5-moUTP): Mechanism & Bench

  2026-06-04

  EZ Cap™ Firefly Luciferase mRNA (5-moUTP) is a next-generation, 5-moUTP-modified, in vitro transcribed mRNA reporter enabling robust expression and immune-silenced bioluminescent assays. Its Cap 1 structure and optimized poly(A) tail deliver enhanced stability and translation efficiency for gene regulation and mRNA delivery studies.

• GSK621: AMPK Agonist Workflows for AML & Immunometabolic Res

  2026-06-03

  GSK621, a potent AMPK agonist from APExBIO, delivers unparalleled control over metabolic reprogramming and cell fate in acute myeloid leukemia (AML) and immunometabolic assays. This article details hands-on protocols, troubleshooting, and advanced applications for maximizing AMPK pathway interrogation and translational impact.

8312 records 11/555 page Previous Next First page 上5页 1112131415 下5页 Last page